Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Integer Holdings Corp(ITGR)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ITGR
09/25/2026: ITGR (3-star) is a STRONG-BUY. BUY for 89 days. Simulated Profits (38.09%). Updated daily EoD!
Integer Holdings Corp is a key provider of specialized components and manufacturing services for the medical device industry, focusing on cardiac, neuromodulation, and vascular technologies. Its core strength lies in its material science expertise and its role as a strategic partner to large medical OEMs, which creates reliable barriers to entry. The company's growth story is centered on the ongoing trend of medical device companies outsourcing manufacturing to focus on their own R&D. Key risks include heavy dependence on a few major customers and potential competitive pressures from lower-cost providers. As a non-dividend-paying stock, it is primarily suited for growth-oriented investors who should monitor OEM outsourcing trends and acquisition integration performance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company benefits from long-term secular growth trends in the outsourced medical device market. |
| Momentum investor | Mixed fit | The stock tends to trend with positive broader medical device market sentiment, conditional on strong earnings reports. |
| Value investor | Mixed fit | Valuation is often tied to growth expectations rather than traditional deep-value metrics. |
| Dividend investor | Weak fit | The company does not pay a dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Weak fit | Stock price volatility and sector-specific risks make it better suited for investors with a higher risk tolerance. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock is susceptible to fluctuations based on sector sentiment and broader market conditions. |
| Valuation risk | Medium | Growth expectations are built into the current price, requiring consistent execution to maintain multiples. |
| Competition risk (OEM in-sourcing) | Medium | The threat of large medical OEMs taking manufacturing back in-house remains a structural industry risk. |
| Business quality | Strong | Integer provides mission-critical components, establishing strong switching costs for its customers. |
| Dividend income | Low / none | Income-seeking investors will not find current yield-based returns. |
| Execution risk | Medium | Ongoing integration of acquisitions and operational efficiency goals requires high management discipline. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 64.77% | Avg. Invested days 66 | Today’s Advisory Regular Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/25/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.29B USD | Price to earnings Ratio 34.57 | 1Y Target Price 121.8 |
Price to earnings Ratio 34.57 | 1Y Target Price 121.8 | ||
Volume (30-day avg) 717.4K shares | Beta 0.61 | 52 Weeks Range 62.00 - 126.80 | Updated Date 09/25/2026 |
52 Weeks Range 62.00 - 126.80 | Updated Date 09/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.65 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Medical Product Sales | Components for cardiac, neuromodulation, and vascular devices. | The company makes the 'guts' of many life-saving medical devices. |
| Non-Medical/Energy | Specialized batteries for military and energy sectors. | A small but stable source of revenue leveraging similar battery technology. |
| Geography | Global operations with heavy manufacturing in the US, Mexico, and Ireland. | The company has an international footprint designed to balance costs and regulatory reach. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 34.57 | Forward PE 22.42 | Enterprise Value 5.64B | Price to Sales(TTM) 2.33 |
Enterprise Value 5.64B | Price to Sales(TTM) 2.33 | ||
Enterprise Value to Revenue 3.06 | Enterprise Value to EBITDA 18.39 | Shares Outstanding 34.00M | Shares Floating 33.65M |
Shares Outstanding 34.00M | Shares Floating 33.65M | ||
Percent Insiders 1.02 | Percent Institutions 123.35 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Integer Holdings Corp
Exchange NYSE | Headquarters Plano, TX, United States | ||
IPO Launch date 2000-09-29 | CEO, President & Director Mr. Payman Khales | ||
Sector Healthcare | Industry Medical Devices | Full time employees 11000 | Website https://www.integer.net |
Full time employees 11000 | Website https://www.integer.net | ||
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.